We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$3.01B
AUM Growth
-$77.5M
Cap. Flow
-$45.6M
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.99%
Holding
119
New
6
Increased
40
Reduced
57
Closed
7

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.4M
2
TDY icon
Teledyne Technologies
TDY
+$17.1M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$14.5M
4
IQV icon
IQVIA
IQV
+$13.6M
5
R icon
Ryder
R
+$12M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Financials 13.03%
3 Communication Services 10.89%
4 Industrials 10.55%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.06T
$195M 6.48%
1,117,419
+1,784
+0.2% +$327K
AAPL icon
2
Apple
AAPL
$4.72T
$166M 5.51%
652,506
+205
+0% +$53.4K
MSFT icon
3
Microsoft
MSFT
$2.83T
$126M 4.2%
341,325
+1,609
+0.5% +$673K
AMZN icon
4
Amazon
AMZN
$2.51T
$93.3M 3.1%
448,052
-1,506
-0.3% -$332K
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$3.88T
$91.2M 3.03%
317,123
+4,793
+2% +$1.51M
AVGO icon
6
Broadcom
AVGO
$1.87T
$70.8M 2.35%
228,819
-8,001
-3% -$2.63M
LITE icon
7
Lumentum
LITE
$64.9B
$64.5M 2.15%
91,844
-16,912
-16% -$9.29M
XOM icon
8
ExxonMobil
XOM
$650B
$64.4M 2.14%
379,572
-2,504
-0.7% -$365K
META icon
9
Meta Platforms (Facebook)
META
$1.54T
$60.8M 2.02%
106,264
-3,505
-3% -$2.25M
VRT icon
10
Vertiv
VRT
$117B
$60.4M 2.01%
241,147
-16,399
-6% -$3.64M
WDC icon
11
Western Digital
WDC
$192B
$56.1M 1.87%
207,494
-35,872
-15% -$9.36M
JPM icon
12
JPMorgan Chase
JPM
$930B
$52.4M 1.74%
178,152
-4,087
-2% -$1.24M
MU icon
13
Micron Technology
MU
$1.12T
$48.3M 1.61%
143,092
-29,895
-17% -$11.7M
HWM icon
14
Howmet Aerospace
HWM
$115B
$47.5M 1.58%
206,271
-10,092
-5% -$2.35M
GOOG icon
15
Alphabet (Google) Class C
GOOG
$3.88T
$46.6M 1.55%
162,389
+247
+0.2% +$77.6K
WELL icon
16
Welltower
WELL
$174B
$43.9M 1.46%
222,073
-2,080
-0.9% -$411K
PWR icon
17
Quanta Services
PWR
$98.1B
$40.6M 1.35%
73,952
-2,987
-4% -$1.54M
TJX icon
18
TJX Companies
TJX
$170B
$38.5M 1.28%
241,227
-869
-0.4% -$135K
LLY icon
19
Eli Lilly
LLY
$1.06T
$38.2M 1.27%
41,570
-214
-0.5% -$217K
JNJ icon
20
Johnson & Johnson
JNJ
$624B
$37.4M 1.24%
153,148
+4,292
+3% +$1,000K
RTX icon
21
RTX Corp
RTX
$282B
$36.8M 1.22%
191,007
+13
+0% +$2.58K
ETR icon
22
Entergy
ETR
$54B
$35.3M 1.17%
313,845
-2,768
-0.9% -$278K
LRCX icon
23
Lam Research
LRCX
$400B
$34.4M 1.14%
160,780
-2,567
-2% -$574K
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.06T
$34.3M 1.14%
71,622
-1,167
-2% -$573K
TRV icon
25
Travelers Companies
TRV
$78.5B
$34M 1.13%
116,402
-762
-0.7% -$223K

Similar funds

Braun Stacey Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Braun Stacey Associates held 119 positions worth $3.01B, down 2.5% from $3.09B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Braun Stacey Associates's Q1 2026 filing shows 6 new, 40 increased, 57 reduced and 7 closed positions. Its largest new stake was Merck: 246,022 shares worth $29.6M. The largest sale was Neurocrine Biosciences, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q1 2026 buy was Merck: 246,022 shares worth $29.6M.
  • Braun Stacey Associates added most to Ascendis Pharma A/S in Q1 2026, an estimated $2.67M increase.
  • Braun Stacey Associates's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $12.1M.
  • Braun Stacey Associates fully exited Neurocrine Biosciences in Q1 2026, selling an estimated $25.9M.
  • Braun Stacey Associates's ten largest holdings make up 33% of its $3.01B portfolio in Q1 2026.
  • Braun Stacey Associates opened 6 new positions and closed 7 in Q1 2026.
  • Braun Stacey Associates's portfolio value fell 2.5% quarter-over-quarter to $3.01B.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.